The use of alpha-2-macroglobulin as a novel treatment for patients with chronic pelvic pain syndrome

Int J Gynaecol Obstet. 2021 Mar;152(3):454-456. doi: 10.1002/ijgo.13423. Epub 2020 Nov 1.

Authors

Brocha Brooks^{1

2

3}, Kim Leishear^{1

2}, Rebecca Aronson^{1

2}, Melanie Howell^{1

2}, Allen Khakshooy³, Michael Pico⁴, Allyson Shrikhande^{1

2}

Affiliations

¹ Pelvic Rehabilitation Medicine Clinical Research Foundation, New York, NY, USA.
² The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
³ The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
⁴ Rusk Rehabilitation, NYU Langone Medical Center, New York, NY, USA.

PMID: 33063845
DOI: 10.1002/ijgo.13423

No abstract available

Keywords: A2M protein; Central sensitization; Chronic pain; Neurogenic inflammation; Neuropathic pain; Pelvic floor disorders; Pelvic pain.